Lane Neidig, MD
Dermatology · Annapolis, MDNPI 1851779573
Payments from drug & device makers
Across 561 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- AbbVie$1K
- Incyte Corporation$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Sun Pharmaceutical Industries Inc.$966
- Sanofi$834
- plus $6K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 74 | $1,355 |
| AbbVie | 48 | $1,073 |
| Incyte Corporation | 41 | $1,051 |
| Regeneron Healthcare Solutions, Inc. | 39 | $1,022 |
| Sun Pharmaceutical Industries Inc. | 31 | $966 |
| Sanofi | 30 | $834 |
| Pfizer | 44 | $828 |
| Dermavant Sciences, Inc. | 42 | $760 |
| Lilly USA, LLC | 31 | $737 |
| Novartis | 26 | $520 |
| Arcutis Biotherapeutics, Inc. | 14 | $375 |
| UCB, Inc. | 18 | $371 |
| LEO Pharma Inc. | 14 | $339 |
| Galderma Laboratories, L.p. | 22 | $316 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 24 | $278 |
| Boehringer Ingelheim | 8 | $217 |
| E.r. Squibb & Sons, L.L.C. | 8 | $157 |
| Biofrontera Inc. | 7 | $153 |
| Verrica Pharmaceuticals Inc. | 2 | $147 |
| Mayne Pharma Commercial LLC | 7 | $112 |
| Organon | 4 | $109 |
| Janssen Scientific Affairs, LLC | 1 | $100 |
| Amgen | 4 | $86 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| LNHC, Inc | 3 | $60 |
| VYNE Pharmaceuticals Inc. | 3 | $56 |
| Kyowa Kirin, Inc. | 2 | $53 |
| Elekta, Inc. | 1 | $46 |
| Strata Skin Sciences, Inc. | 6 | $46 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $28 |
| Organogenesis Inc. | 1 | $26 |
| Dermira, Inc. | 1 | $24 |
| Botanix SB Inc | 1 | $22 |
| Almirall LLC | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$12,380 in reported general payments places this provider in the 80th percentile of 306 dermatology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Annapolis
- Benjamin LockshinSilver Spring$6.6M
- Shawn KwatraBaltimore$2.4M
- Robert WeissHunt Valley$2.3M
- Rebecca KazinChevy Chase$1.7M
- Chesahna Kindred WeaverMarriottsville$1.4M
- Valerie CallenderGlenn Dale$822K
- Oanh LauringNottingham$763K
- Lloyd MillerBaltimore$752K
- Ronald PrussickN Bethesda$630K
- Pantea TamjidiChevy Chase$541K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.